Sign in
CompletedNo phase

A Study to Learn About the Occurrence of ADHD in Adults With Mental Conditions and Their Quality of Life

Key facts

Who runs it
Takeda
Where
Canada, Germany, Spain, Sweden, Switzerland, and United Kingdom14 sites in 6 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
224 people enrolled
Started
6 Nov 2023
Ended
28 Jul 2025
Type of study
Observational, 2 groups
Record updated
14 October 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Part I:
  • Adult greater than or equal to (>=)18 years of age or Canadian adult >=19 years of age
  • Ability to consent, as judged by the study investigator
  • Diagnosis of at least one psychiatric disorder of at least 12 months duration, based on International classification of diseases (ICD)-10 codes registered in electronic health records
  • Consecutive assessment for ADHD (as per routine clinical practice)
  • Able to read and write in the first language of the respective country; Part II
  • Inclusion in study Part I
  • Diagnosis of ADHD during Part I, according to routine diagnostic procedure and algorithms
  • Anticipated availability for being followed over 9 months

Who cannot take part

  • Diagnosis of any of the following at any time prior to signing informed consent: schizoaffective disorder, intellectual disability, or other cognitive disorders
  • Occurrence of any of the following events within the 6 months prior to signing consent: psychotic episodes, acute intoxication, or psychotropic drug withdrawal syndrome
  • Participation in a clinical interventional trial in the 12 months prior signing consent; Part II:
  • Serious and unstable medical condition (severe disease that limits survival to 1 year)
  • Part I:
  • Diagnosis of ADHD at any time before study inclusion
  • Participant being followed-up for ADHD in a different site

This trial has no sites in United States.

It has sites in 6 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

The main aim of the study is to find out how frequently adults with at least one psychiatric condition have ADHD (but have not been diagnosed with ADHD before) and to describe the quality of life of these adults who have been diagnosed with ADHD. To find out how often ADHD is not diagnosed in these adults could provide awareness about this condition and could help to improve preventing underdiagnosis.

The 2 groups in the trial

  • Part I: Participants with ADHD

    Participants with psychiatric disorders undergoing ADHD diagnosis.

  • Part II: Participants with ADHD

    To collect pseudonymized data from participants who are underdiagnosed of ADHD with psychiatric disorders in daily clinical practice for up to 9 months from both Part I and II.

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Prevalence of ADHD and Health Outcomes in Adult Outpatients With Psychiatric Disorders: a Multi-country, Two-part, Observational Study
Record updated
14 October 2025